Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.1%

148 terminated/withdrawn out of 1625 trials

Success Rate

84.6%

-2.0% vs industry average

Late-Stage Pipeline

11%

177 trials in Phase 3/4

Results Transparency

8%

67 of 810 completed trials have results

Key Signals

259 recruiting67 with results103 terminated45 withdrawn

Enrollment Performance

Analytics

N/A
670(53.6%)
Phase 2
274(21.9%)
Phase 1
119(9.5%)
Phase 4
89(7.1%)
Phase 3
88(7.0%)
Early Phase 1
10(0.8%)
1250Total
N/A(670)
Phase 2(274)
Phase 1(119)
Phase 4(89)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1625)

Showing 20 of 1625 trials
NCT04566887Phase 2Active Not Recruiting

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Role: lead

NCT07456605Phase 1Recruiting

Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma

Role: lead

NCT06442930Recruiting

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Role: lead

NCT06930521Not ApplicableRecruiting

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year

Role: collaborator

NCT07631052Phase 2Recruiting

Capecitabine in ER+/HER2-negative Breast Cancer

Role: lead

NCT01542177Completed

A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer

Role: lead

NCT03488966Not ApplicableActive Not Recruiting

Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients

Role: lead

NCT06451445Not ApplicableRecruiting

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

Role: lead

NCT07641842Not Yet Recruiting

Shoulder RA Survey Study

Role: lead

NCT07509450Not ApplicableRecruiting

Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study

Role: lead

NCT06823661Not ApplicableCompleted

Transcutaneous Electrical Stimulation for Apnea Detected by Capnography

Role: collaborator

NCT02481635Phase 1Active Not Recruiting

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

Role: lead

NCT06050707Phase 2Recruiting

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Role: lead

NCT06107868Phase 1Active Not Recruiting

Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

Role: lead

NCT07636382Not ApplicableRecruiting

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

Role: lead

NCT05403177Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Role: lead

NCT04054609Not ApplicableRecruiting

FAZA PET/MRI in CLI Patients Pre and Post Revascularization

Role: lead

NCT04243720Recruiting

Immune Resistance Interrogation Study

Role: lead

NCT00901160Terminated

Thromboelastography (TEG®) and Platelet Function in Patients on Anti-platelet Agents

Role: collaborator

NCT04811209Recruiting

MCID and PASS for Acute Pain and Quality of Recovery After Orthopedic Surgery

Role: lead